Loading...
DOCUMENTS
20
NOTICES
33
MOTS CLES
Over 80s
Heart disease risk factors
Tuberculosis
IL12
DNA methylation
MORTALITY
MARKER
Neoadjuvant chemotherapy
Gene expression
Cell adhesion
Résistance
Disease Progression
Survival
Eradication
Monitoring
MICROBIOTA
Biologics
Surgery
Venous thromboembolism
Tailored therapy
Microbiote
Drug
Clinical trial
Crohn's disease
Colectomy
Endoscopic treatment
Dysbiose
IBD
Patients experience
Méthylation
Anti-TNF agents
Parvimonas micra
Colorectal cancer
Genes
CARCINOGENESIS
Biomarker
Original Article Clinical
Consensus
Immune cells
Inflammatory bowel disease
Methylation
Cancer
Gènes
Algorithm
Dysbiosis
HIV
T1118 translocation
MALT
Ulcerative colitis
Inflammatory bowel diseases
Inflammatory Bowel Diseases
Clinical guidelines
Inclusion
Crohn’s disease
Epigénétiques
Kidney diseases
PCR
Effectiveness
Colorectal cancer Colibactin and lipids
Bactéries
Inhibitor
COLON-CANCER
Helicobacter pylori
Maintenance therapy
Patient-reported outcome
Alkylating agents
Contraindication
Primary sclerosing cholangitis
Intestinal crypts
Rituximab plus chlorambucil
Disability
Colonic epithelial primary cells
Ustekinumab
Screening
IL23
DNA METHYLATION
Safety
Epigenetics
RISK
Stricture
Resistance
Immunosuppressant
Colon
Gene methylation
Vedolizumab
Acceptability
Rituximab
Upper gastrointestinal tract
Cost effectiveness
18 FDG-PET/CT
Eligibility
Therapeutics
Small molecules
Fecal microbiota
Disease progression
Thérapie ciblée
Bacteria
Microbiota
Anti-TNF
Colon cancer
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|